Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil E Kay

Showing results (91-100 of 325) with videos related to

Pageof 33
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
Chronic lymphocytic leukemia is associated with decreased survival of patients with malignant melanoma and Merkel cell carcinoma in a SEER population-based studyJerry D Brewer, Tait D Shanafelt, Clark C Otley, et al.
Leukemia Research|July 22, 2008
Computational identification of CDR3 sequence archetypes among immunoglobulin sequences in chronic lymphocytic leukemiaBradley T Messmer, Benjamin J Raphael, Sarah J Aerni, et al.
British Journal of Haematology|July 17, 2009
Pretreatment angiogenic cytokines predict response to chemoimmunotherapy in patients with chronic lymphocytic leukaemiaTait D Shanafelt, John C Byrd, Betsy LaPLant, et al.
Future Oncology (London, England)|June 6, 2014
The HELIOS trial protocol: a phase III study of ibrutinib in combination with bendamustine and rituximab in relapsed/refractory chronic lymphocytic leukemiaMichael Hallek, Neil E Kay, Anders Osterborg, et al.
Blood|November 8, 2014
Deep sequencing identifies genetic heterogeneity and recurrent convergent evolution in chronic lymphocytic leukemiaJuhi Ojha, Jackline Ayres, Charla Secreto, et al.
American Journal of Epidemiology|September 13, 2002
Anthropometric characteristics, physical activity, and risk of non-Hodgkin's lymphoma subtypes and B-cell chronic lymphocytic leukemia: a prospective studyJames R Cerhan, Carol A Janney, Celine M Vachon, et al.
British Journal of Haematology|September 28, 2007
Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patientsTait D Shanafelt, Deborah Bowen, Chaya Venkat, et al.
Leukemia|October 7, 2018
Bone marrow hematopoietic dysfunction in untreated chronic lymphocytic leukemia patientsBryce A Manso, Henan Zhang, Molly G Mikkelson, et al.
Human Molecular Genetics|August 4, 2020
Chronic lymphocytic leukemia (CLL) risk is mediated by multiple enhancer variants within CLL risk lociHuihuang Yan, Shulan Tian, Geffen Kleinstern, et al.
Blood|July 3, 2010
LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosisAlbert Gutierrez, Renee C Tschumper, Xiaosheng Wu, et al.
Pageof 33

Showing results (91-100 of 325) with videos related to

Sort By:
Pageof 33
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
Chronic lymphocytic leukemia is associated with decreased survival of patients with malignant melanoma and Merkel cell carcinoma in a SEER population-based studyJerry D Brewer, Tait D Shanafelt, Clark C Otley, et al.
Leukemia Research|July 22, 2008
Computational identification of CDR3 sequence archetypes among immunoglobulin sequences in chronic lymphocytic leukemiaBradley T Messmer, Benjamin J Raphael, Sarah J Aerni, et al.
British Journal of Haematology|July 17, 2009
Pretreatment angiogenic cytokines predict response to chemoimmunotherapy in patients with chronic lymphocytic leukaemiaTait D Shanafelt, John C Byrd, Betsy LaPLant, et al.
Future Oncology (London, England)|June 6, 2014
The HELIOS trial protocol: a phase III study of ibrutinib in combination with bendamustine and rituximab in relapsed/refractory chronic lymphocytic leukemiaMichael Hallek, Neil E Kay, Anders Osterborg, et al.
Blood|November 8, 2014
Deep sequencing identifies genetic heterogeneity and recurrent convergent evolution in chronic lymphocytic leukemiaJuhi Ojha, Jackline Ayres, Charla Secreto, et al.
American Journal of Epidemiology|September 13, 2002
Anthropometric characteristics, physical activity, and risk of non-Hodgkin's lymphoma subtypes and B-cell chronic lymphocytic leukemia: a prospective studyJames R Cerhan, Carol A Janney, Celine M Vachon, et al.
British Journal of Haematology|September 28, 2007
Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patientsTait D Shanafelt, Deborah Bowen, Chaya Venkat, et al.
Leukemia|October 7, 2018
Bone marrow hematopoietic dysfunction in untreated chronic lymphocytic leukemia patientsBryce A Manso, Henan Zhang, Molly G Mikkelson, et al.
Human Molecular Genetics|August 4, 2020
Chronic lymphocytic leukemia (CLL) risk is mediated by multiple enhancer variants within CLL risk lociHuihuang Yan, Shulan Tian, Geffen Kleinstern, et al.
Blood|July 3, 2010
LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosisAlbert Gutierrez, Renee C Tschumper, Xiaosheng Wu, et al.
Pageof 33